Cell cycle arrest attenuate protected from chemotherapy induced. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy8

Cell Line, Tumor Tumor Cells, Cultured Cell Line Cells, Cultured Cell Nucleus HeLa Cells Fibroblasts Spindle Apparatus

Organisms5

Saccharomyces cerevisiae Mice, Nude Schizosaccharomyces Caulobacter crescentus Life Cycle Stages

Diseases39

Breast Neoplasms Lung Neoplasms Neoplasms Neoplasm Recurrence, Local Adenocarcinoma Ovarian Neoplasms Carcinoma, Non-Small-Cell Lung Neoplasm Metastasis Neutropenia Testicular Neoplasms Colorectal Neoplasms Lymphoma, Non-Hodgkin Vomiting Osteosarcoma Hodgkin Disease Nausea Liver Neoplasms Brain Neoplasms Bone Neoplasms Stomach Neoplasms Carcinoma Neoplasms, Germ Cell and Embryonal Carcinoma, Squamous Cell Leukopenia Disease Progression Colonic Neoplasms Lymphatic Metastasis Recurrence Lymphoma Peritoneal Neoplasms Leukemia, Myeloid, Acute Precursor Cell Lymphoblastic Leukemia-Lymphoma Germinoma Head and Neck Neoplasms Pancreatic Neoplasms Thrombocytopenia Sarcoma Lymphoma, Large B-Cell, Diffuse Cell Transformation, Neoplastic

Chemicals and Drugs105

Cell Cycle Proteins Antineoplastic Agents Cisplatin Doxorubicin Cyclophosphamide Cyclins Etoposide Paclitaxel Cyclin-Dependent Kinase Inhibitor p21 Cyclin-Dependent Kinase Inhibitor p27 Tumor Suppressor Protein p53 Methotrexate Retinoblastoma Protein Carboplatin Vinblastine Taxoids CDC2 Protein Kinase Antimetabolites, Antineoplastic Antineoplastic Agents, Phytogenic Protein-Serine-Threonine Kinases Deoxycytidine DNA-Binding Proteins Bleomycin Ifosfamide Cyclin D1 Cyclin-Dependent Kinase 2 Cyclin E Antineoplastic Agents, Alkylating Organoplatinum Compounds Tumor Suppressor Proteins Cyclin A Nuclear Proteins Cytarabine Cyclin B Cyclin-Dependent Kinase 4 RNA, Messenger Anthracyclines Antibiotics, Antineoplastic Transcription Factors CDC2-CDC28 Kinases cdc25 Phosphatases Camptothecin E2F Transcription Factors Cyclin B1 DNA Tumor Markers, Biological Granulocyte Colony-Stimulating Factor Carmustine Mitomycin Bromodeoxyuridine Dacarbazine Cyclin D Lomustine E2F1 Transcription Factor Proto-Oncogene Proteins RNA, Small Interfering Hydroxyurea Saccharomyces cerevisiae Proteins Protein Kinases Melphalan Platinum Compounds Mitoxantrone Enzyme Inhibitors Antiemetics Recombinant Proteins Neoplasm Proteins Thiotepa Antibodies, Monoclonal Antibodies, Monoclonal, Humanized Cyclin D3 Microtubule-Associated Proteins Histones Daunorubicin Cyclin-Dependent Kinase Inhibitor Proteins Tegafur Proliferating Cell Nuclear Antigen Fungal Proteins Cyclin-Dependent Kinase Inhibitor p16 Proto-Oncogene Proteins c-bcl-2 Bridged Compounds Carrier Proteins Ki-67 Antigen Cyclin-Dependent Kinase 6 Cyclin D2 Transcription Factor DP1 Mimosine Recombinant Fusion Proteins Vindesine Receptors, Estrogen Platinum Ubiquitin-Protein Ligase Complexes Receptor, erbB-2 Proto-Oncogene Proteins c-myc DNA, Neoplasm Retinoblastoma-Binding Protein 1 Nocodazole Protein Kinase Inhibitors Anaphase-Promoting Complex-Cyclosome Dexamethasone Tamoxifen Oxonic Acid Schizosaccharomyces pombe Proteins Ataxia Telangiectasia Mutated Proteins DNA Primers Repressor Proteins

Analytical, Diagnostic and Therapeutic Techniques and Equipment45

Antineoplastic Combined Chemotherapy Protocols Chemotherapy, Adjuvant Combined Modality Therapy Treatment Outcome Neoadjuvant Therapy Disease-Free Survival Neoplasm Staging Survival Analysis Prognosis Drug Administration Schedule Survival Rate Induction Chemotherapy Flow Cytometry Follow-Up Studies Models, Biological Chemotherapy, Cancer, Regional Perfusion Salvage Therapy Blotting, Western Transplantation, Autologous Immunohistochemistry Radiotherapy, Adjuvant Radiotherapy Prospective Studies Gene Expression Profiling Clinical Trials as Topic Kaplan-Meier Estimate Transfection Infusions, Intravenous Reverse Transcriptase Polymerase Chain Reaction Hematopoietic Stem Cell Transplantation Infusions, Intra-Arterial Drug Therapy Drug Screening Assays, Antitumor Palliative Care Oligonucleotide Array Sequence Analysis Radiotherapy Dosage Xenograft Model Antitumor Assays Randomized Controlled Trials as Topic Hyperthermia, Induced Chemoradiotherapy Multivariate Analysis Maintenance Chemotherapy Microscopy, Fluorescence Feasibility Studies Cranial Irradiation

Phenomena and Processes49

Cell Cycle Cell Cycle Checkpoints G1 Phase Mitosis S Phase Cell Division Apoptosis Menstrual Cycle G2 Phase Cell Proliferation Time Factors G2 Phase Cell Cycle Checkpoints Drug Resistance, Neoplasm G0 Phase DNA Damage G1 Phase Cell Cycle Checkpoints Phosphorylation Signal Transduction DNA Replication Dose-Response Relationship, Drug Genes, cdc Mutation Interphase Cell Survival Gene Expression Regulation, Neoplastic Estrous Cycle Transcription, Genetic Gene Expression Regulation Cell Differentiation Base Sequence Amino Acid Sequence Down-Regulation Citric Acid Cycle Transfection Protein Binding S Phase Cell Cycle Checkpoints DNA Repair Promoter Regions, Genetic RNA Interference Gene Expression M Phase Cell Cycle Checkpoints Kinetics Drug Synergism Phenotype Up-Regulation Enzyme Activation Genes, p53 Life Cycle Stages Cell Death

Disciplines and Occupations1

Immunohistochemistry

Anthropology, Education, Sociology and Social Phenomena1

Quality of Life

Humanities1

Quality of Life

Information Science4

Survival Rate Molecular Sequence Data Base Sequence Amino Acid Sequence

Health Care12

Treatment Outcome Disease-Free Survival Survival Analysis Survival Rate Follow-Up Studies Prospective Studies Clinical Trials as Topic Kaplan-Meier Estimate Palliative Care Randomized Controlled Trials as Topic Multivariate Analysis Feasibility Studies

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Information Science Health Care

Cell Cycle Antineoplastic Combined Chemotherapy Protocols Cell Cycle Proteins Chemotherapy, Adjuvant Antineoplastic Agents Cell Cycle Checkpoints Cisplatin Combined Modality Therapy Doxorubicin G1 Phase Cyclophosphamide Treatment Outcome Mitosis S Phase Breast Neoplasms Cell Division Cyclins Neoadjuvant Therapy Etoposide Apoptosis Disease-Free Survival Cell Line, Tumor Neoplasm Staging Lung Neoplasms Menstrual Cycle G2 Phase Survival Analysis Cell Proliferation Time Factors Prognosis Drug Administration Schedule Survival Rate Paclitaxel Cyclin-Dependent Kinase Inhibitor p21 Cyclin-Dependent Kinase Inhibitor p27 Tumor Suppressor Protein p53 Methotrexate Neoplasms Retinoblastoma Protein G2 Phase Cell Cycle Checkpoints Carboplatin Vinblastine Drug Resistance, Neoplasm Taxoids Induction Chemotherapy G0 Phase Neoplasm Recurrence, Local CDC2 Protein Kinase Antimetabolites, Antineoplastic DNA Damage Antineoplastic Agents, Phytogenic Flow Cytometry G1 Phase Cell Cycle Checkpoints Protein-Serine-Threonine Kinases Deoxycytidine Phosphorylation DNA-Binding Proteins Bleomycin Ifosfamide Tumor Cells, Cultured Cyclin D1 Cyclin-Dependent Kinase 2 Cell Line Signal Transduction DNA Replication Dose-Response Relationship, Drug Cyclin E Antineoplastic Agents, Alkylating Genes, cdc Organoplatinum Compounds Molecular Sequence Data Tumor Suppressor Proteins Mutation Cyclin A Nuclear Proteins Cytarabine Interphase Adenocarcinoma Ovarian Neoplasms Cell Survival Carcinoma, Non-Small-Cell Lung Cyclin B Cyclin-Dependent Kinase 4 RNA, Messenger Neoplasm Metastasis Anthracyclines Antibiotics, Antineoplastic Follow-Up Studies Gene Expression Regulation, Neoplastic Cells, Cultured Models, Biological Transcription Factors Cell Nucleus Chemotherapy, Cancer, Regional Perfusion CDC2-CDC28 Kinases Salvage Therapy Neutropenia HeLa Cells Testicular Neoplasms Estrous Cycle

No FAQ available that match "cell cycle arrest attenuate protected from chemotherapy induced"